Saltoro Capital, LP - Q1 2023 holdings

$161 Million is the total value of Saltoro Capital, LP's 49 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .

 Value Shares↓ Weighting
 NABORS INDS INCnote 0.750% 1/1$1,930,000
+3.8%
2,000,0000.0%1.20%
-19.5%
 ACORDA THERAPEUTICS INCnote 6.000%12/0$991,164
-11.9%
1,500,0000.0%0.61%
-31.6%
 TEAM INCnote 5.000% 8/0$667,5000.0%750,0000.0%0.41%
-22.3%
CHKEL  CHESAPEAKE ENERGY CORP*w exp 02/09/202$479,011
-15.2%
7,3020.0%0.30%
-34.1%
 XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1$266,223
+29.0%
250,0000.0%0.16%0.0%
 ALGOMA STL GROUP INC*w exp 10/19/202$32,000
+38.5%
20,0000.0%0.02%
+11.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GREEN PLAINS INC12Q3 20236.5%
XERIS PHARMACEUTICALS INC12Q3 20230.3%
ACORDA THERAPEUTICS INC11Q3 20231.0%
TEAM INC11Q2 20230.9%
CHESAPEAKE ENERGY CORP11Q3 20230.5%
ISHARES TR10Q3 202349.6%
GREEN PLAINS INC10Q3 20238.8%
GREEN PLAINS INC9Q3 20236.2%
NABORS INDS INC NEW9Q2 20232.0%
TRAVERE THERAPEUTICS INC8Q3 20221.4%

View Saltoro Capital, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-09
13F-HR2023-05-10
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR/A2022-08-17
13F-HR2022-08-12
13F-HR2022-05-12
13F-HR/A2022-02-09

View Saltoro Capital, LP's complete filings history.

Compare quarters

Export Saltoro Capital, LP's holdings